J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 43 (1979), 473-487; DOI 10.1099/0022-1317-43-3-473
© 1979 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meischke, H. R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meischke, H. R. C.
Agricola
Right arrow Articles by Meischke, H. R. C.

In Vitro Transformation by Bovine Papilloma Virus

H. R. C. Meischke*

Department of Veterinary Pathology, University of Glasgow Veterinary School, Bearsden Road, Glasgow G61 1QH, U.K.

This paper reports the development of a quantal transformation assay for bovine papilloma virus. Support for its specificity to fibropapilloma derived bovine papilloma virus comes from (1) the absence of transformation associated changes following inoculations of normal bovine skin, bovine teat papilloma, bovine teat focal epithelial hyperplasia lesion and canine papilloma derived suspensions; (2) in vitro transformation occurs when CsCl purified fibropapilloma-derived BPV is used; (3) in vitro transformation experiments reported here parallel in vivo transmission of fibropapillomas described elsewhere using the same extracts; (4) the time-temperature inactivation of BPV using in vitro transformation parallels in vivo results and is similar to that reported for other papovaviruses; (5) BPV in vitro transformed cells are tumorigenic in nude mice and increase in vivo resistance in calves to subsequent challenge with fibropapilloma derived virus; (6) inhibition of in vitro transformation by bovine papilloma virus occurs when sera from calves bearing regressing fibropapillomas are used in conjunction with complement; (7) transformation inhibition activity may be adsorbed from high titre sera using BPV-induced tumour cells or in vitro transformed cells but not using various virus suspensions. The detection of BPV in commercially available milk is reported. While it is highly likely that milk-derived BPV is active, no direct evidence is available since the vast majority of teat lesions contain papilloma and focal epithelial hyperplasia-derived BPV which neither transform cultures in vitro, nor produce fibropapillomas in vivo. The work reported here lends further support for the existence of several types of BPV suggested elsewhere.

* Present address: c/o Bureau of Animal Health, Department of Primary Industry, Canberra, Australia.

Received 6 June 1978; accepted 9 November 1978.


This article has been cited by other articles:


Home page
ScienceHome page
R Schlegel, M Wade-Glass, M. Rabson, and Y. Yang
The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide
Science, July 25, 1986; 233(4762): 464 - 467.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1979 by the Society for General Microbiology.